Rankings
▼
Calendar
INDV Q2 2022 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena
INDV
Indivior Pharmaceuticals Inc
$4B
Q2 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$221M
Gross Profit
$183M
82.8% margin
Operating Income
$63M
28.5% margin
Net Income
$48M
21.7% margin
EPS (Diluted)
$0.33
QoQ Revenue Growth
+6.8%
Cash Flow
Operating Cash Flow
$29M
Free Cash Flow
$27M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$1.5B
Stockholders' Equity
$231M
Cash & Equivalents
$859M
← FY 2022
All Quarters
Q3 2022 →
